drugset / Trial / NCT03506763

Effect of Pre-medication in Pain Measures on Office Hysteroscopy

NCT03506763

Phase 4 Unknown 231 enrolled Hospital de Clinicas de Porto Alegre
RandomizedSequentialTriple-blindTreatment

Summary

Will be perform a RCT to compare pain measure on office hysteroscopy after pre-medication with oral analgesic. Patients will be alocate to oral sodic diclofenac, scopolamin or placebo. We will compare visual analog score of pain after the procedure. Patients: patients with indication of office hysteroscopy to evaluate uterine intracavitary abnormality. Interventions Group 1 (control) The patients will receive about 2 h prior to the procedure 2 placebo tablets. Group 2 (diclofenac + scopolamine) The patients will receive about 2 h prior to the procedure 1 tablet of diclofenac sodium 50 mg and 1 tablet of scopolamine 2 mg. Group 3 (diclofenac only). Patients will receive approximately 2 h prior to the procedure 1 tablet of diclofenac sodium 50 mg and 1 tablet of placebo.

Timeline

Start
2017-08-01
Primary completion
2018-12-31
Completion
2019-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Diclofenac Other / unclassified 50 mg Oral
Comparator Scopolamine Unknown 2 mg Oral

Indications

No indication recorded.